Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people
Snape, Natale, Anderson, Gary P., Irving, Louis B., Jarnicki, Andrew G., Hurt, Aeron C., Collins, Tina, Xi, Yang, and Upham, John W. (2022) Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people. NPJ Vaccines, 7. 8.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution. Download (952kB) | Preview |
Abstract
Though clinical guidelines recommend influenza vaccination for chronic obstructive pulmonary disease (COPD) patients and other high-risk populations, it is unclear whether current vaccination strategies induce optimal antibody responses. This study aimed to identify key variables associated with strain-specific antibody responses in COPD patients and healthy older people. 76 COPD and 72 healthy participants were recruited from two Australian centres and inoculated with influenza vaccine. Serum strain-specific antibody titres were measured pre- and post-inoculation. Seroconversion rate was the primary endpoint. Antibody responses varied between vaccine strains. The highest rates of seroconversion were seen with novel strains (36–55%), with lesser responses to strains included in the vaccine in more than one consecutive year (27–33%). Vaccine responses were similar in COPD patients and healthy participants. Vaccine strain, hypertension and latitude were independent predictors of seroconversion. Our findings reassure that influenza vaccination is equally immunogenic in COPD patients and healthy older people; however, there is room for improvement. There may be a need to personalise the yearly influenza vaccine, including consideration of pre-existing antibody titres, in order to target gaps in individual antibody repertoires and improve protection.
| Item ID: | 74889 |
|---|---|
| Item Type: | Article (Research - C1) |
| ISSN: | 2059-0105 |
| Copyright Information: | © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| Funders: | National Health & Medical Research Council (NHMRC) |
| Projects and Grants: | NHMRC Australia (grant number #APP1081433) |
| Date Deposited: | 12 Jul 2022 02:01 |
| FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3204 Immunology > 320405 Humoural immunology and immunochemistry @ 50% 42 HEALTH SCIENCES > 4206 Public health > 420699 Public health not elsewhere classified @ 20% 31 BIOLOGICAL SCIENCES > 3107 Microbiology > 310706 Virology @ 30% |
| SEO Codes: | 20 HEALTH > 2001 Clinical health > 200104 Prevention of human diseases and conditions @ 100% |
| Downloads: |
Total: 648 Last 12 Months: 16 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |